JESSICA CASALE: Open Payments
NPI 1942533427 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 30 payments from 10 companies in 2025. Trend: 2023 $588 · 2024 $971 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $208 |
| PFIZER INC. | 7 | $141 |
| Novo Nordisk Inc | 6 | $109 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Boston Scientific Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: BREZTRI, NURTEC ODT, Ozempic, AIRSUPRA, FARXIGA, Wegovy, MOUNJARO, PREVNAR 20.
Industry payments across DE — which companies pay providers there.
